Drug Substance Product Integration - An Innovation in Pharma

Drug substance product integration speeds drug development, cuts costs, and enhances quality, delivering innovative medicines to patients faster.

Projected Growth of Injectable Drug Market To $1139B By 2029

Expected to grow 9% annually, the injectable drug market could hit $1139B by 2029, with demand for treatments like TB, HIV, and vaccinations fueling growth.

Biotech And CDMOs: Overcoming Drug Development Challenges

Collaborations between biotech firms and CDMOs mitigate risks, boost efficiency, and improve the success rates in the complicated drug development process.

CDMO Market For Small Molecule Innovation Soars By 2033

The small molecule CDMO market is expected to grow at a CAGR of 6.4%, rising from $48.09B in 2023 to $89.43B by 2033, boosted by rising demand and innovation.

5 CDMO Partnership Models Reshaping Pharma Manufacturing

The pharma manufacturing landscape is going through a major shift with CDMO partnership models making significant strides to reshape it and act as a partner.

Challenges And Solutions For Cell And Gene Therapies By CDMOs

CGTs require ultra-cold storage, posing unique challenges. CDMOs invest in advanced tech and solutions to ensure product viability and distribution efficiency.

The Biopharma CDMO Market Surges With Outsourcing Growth

86.9% of the biopharma CDMO market is made up of outsourcing, and trends are growing in China and India. There is also a greater need for new technologies.